Literature DB >> 22885251

Matrix metalloproteinases in skeletal muscles: friends or foes?

Hala S Alameddine1.   

Abstract

Matrix metalloproteinases (MMPs) are members of an enzyme family that require a zinc ion at their active site. Active at neutral pH, they catalyze normal turnover of extracellular matrix (ECM) and are critical for maintaining tissue allostasis. Subtle coordination between MMP activity and its inhibition by tissue inhibitors of metalloproteinases (TIMPs) insures ECM homeostasis. Loss of control of MMPs expression/activity in numerous pathologies usually associates with host response to injuries, facilitation of disease progression and significant tissue damage. In skeletal muscles, fragmentary knowledge of MMPs/TIMPs regulation and function underscores the need for a better understanding of their role which may lead to therapeutic alternatives. This review presents the current knowledge of MMPs in the biology and pathology of skeletal muscles and puts into perspective therapeutic alternatives that could be challenged in experimental models or that might emerge from in depth investigation of MMPs/TIMPs status in neuromuscular diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885251     DOI: 10.1016/j.nbd.2012.07.023

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

Review 1.  MMP-14 in skeletal muscle repair.

Authors:  C Snyman; C U Niesler
Journal:  J Muscle Res Cell Motil       Date:  2015-05-30       Impact factor: 2.698

Review 2.  Tissutal and Fluidic Aspects in Osteopathic Manual Therapy: A Narrative Review.

Authors:  Marco Verzella; Erika Affede; Luca Di Pietrantonio; Vincenzo Cozzolino; Luca Cicchitti
Journal:  Healthcare (Basel)       Date:  2022-05-31

3.  Force dependent effects of chronic overuse on fibrosis-related genes and proteins in skeletal muscles.

Authors:  Brendan A Hilliard; Mamta Amin; Steven N Popoff; Mary F Barbe
Journal:  Connect Tissue Res       Date:  2020-10-08       Impact factor: 3.417

Review 4.  Actions and interactions of IGF-I and MMPs during muscle regeneration.

Authors:  Hui Jean Kok; Elisabeth R Barton
Journal:  Semin Cell Dev Biol       Date:  2021-05-05       Impact factor: 7.499

5.  Resistance exercise increases active MMP and β1-integrin protein expression in skeletal muscle.

Authors:  Riki Ogasawara; Koichi Nakazato; Koji Sato; Marni D Boppart; Satoshi Fujita
Journal:  Physiol Rep       Date:  2014-11-20

Review 6.  MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix.

Authors:  Max E Davis; Jonathan P Gumucio; Kristoffer B Sugg; Asheesh Bedi; Christopher L Mendias
Journal:  J Appl Physiol (1985)       Date:  2013-05-02

7.  The relationship between primary sarcopenia and SARC-F, serum MMP9, TIMP1 levels, and MMP9/TIMP1 ratio in the geriatric patients.

Authors:  Veysel Suzan; Hakan Yavuzer; Rabia Bag Soytas; Bahar Bektan Kanat; Pinar Arman; Tugce Emiroglu Gedik; Damla Unal; Oguz Atar; Ibrahim Murat Bolayirli; Alper Doventas
Journal:  Eur Geriatr Med       Date:  2021-06-09       Impact factor: 1.710

8.  Regeneration of soft tissues is promoted by MMP1 treatment after digit amputation in mice.

Authors:  Xiaodong Mu; Ian Bellayr; Haiying Pan; Yohan Choi; Yong Li
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

9.  Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.

Authors:  Sajedah M Hindi; Jonghyun Shin; Yuji Ogura; Hong Li; Ashok Kumar
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

10.  Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis.

Authors:  Takayuki Nakamura; Tatsuya Okada; Motoyoshi Endo; Tsuyoshi Kadomatsu; Takuya Taniwaki; Akira Sei; Haruki Odagiri; Tetsuro Masuda; Toru Fujimoto; Takafumi Nakamura; Yuichi Oike; Hiroshi Mizuta
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.